Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating gallstones and preparation method of pharmaceutical composition

A composition and a technique for gallstones, applied in the field of treating gallstones, can solve the problems of easy recurrence of gallstones, insignificant effect, slow effect, etc., and achieve the effects of no toxic and side effects, good stone removal effect, and quick effect.

Inactive Publication Date: 2016-05-25
粟春生
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to provide a pharmaceutical composition for gallstones, so as to overcome the shortcomings of easy recurrence, slow effect and insignificant effect in the existing treatment of gallstones

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] A pharmaceutical composition for gallstones, comprising: 20 parts of Desmodium, 12 parts of Curcuma, 7 parts of Eucommia ulmoides, 20 parts of capillary, 14 parts of Scutellaria baicalensis, 8 parts of Citrus aurantii, 2 parts of licorice, 22 parts of Radix Paeoniae Alba in parts by weight. 13 parts of Albizia Julibrissin, 5 parts of Polygonum cuspidatum, 4 parts of Muxiang, 11 parts of Gentiana, and 5 parts of Bupleurum.

[0032] A preparation method of a gallstone pharmaceutical composition, comprising the following steps:

[0033] (1) Weigh the raw materials needed for production;

[0034] (2) For the first decoction, soak the raw medicine in water, then decoct with strong fire until boiling, then decoct with slow fire for 40 minutes, take out the medicine juice, and leave the remaining medicine residue;

[0035] (3) Decocting for the second time, adding water to the remaining medicinal residues in the step (2) for decoction, decocting with a slow fire for 40 minute...

Embodiment 2

[0038] The difference between this example and Example 1 is that a pharmaceutical composition for gallstones comprises, in parts by weight: 10 parts of Desmodium, 5 parts of Curcuma, 5 parts of Eucommia, 10 parts of capillary, 10 parts of Scutellaria, 5 parts of shell, 1 part of licorice, 10 parts of white peony, 5 parts of albizia juniper, 1 part of knotweed, 1 part of woody fragrance, 5 parts of gentian, and 5 parts of Bupleurum.

Embodiment 3

[0040] The difference between this example and Example 1 is that a pharmaceutical composition for gallstones comprises, in parts by weight: 30 parts of Desmodium, 20 parts of Curcuma ulmoides, 15 parts of Eucommia ulmoides, 30 parts of capillary, 20 parts of Scutellaria baicalensis, 15 parts of shell, 5 parts of licorice, 30 parts of white peony root, 20 parts of albizia julibrissin, 10 parts of knotweed, 10 parts of woody fragrance, 15 parts of gentian root, and 10 parts of Bupleurum.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating gallstones. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 10-30 parts of lysimachia christinae hance, 5-20 parts of radix curcumae, 5-15 parts of eucommia ulmoides, 10-30 parts of oriental wormwood, 10-20 parts of scutellaria baicalensis, 5-15 parts of fructus aurantii, 1-5 parts of liquorice, 10-30 parts of radix paeoniae alba, 5-20 parts of albizia flowers, 1-10 parts of polygonum cuspidatum, 1-10 parts of elecampane, 5-15 parts of gentian root and 5-10 parts of radix bupleuri. The pharmaceutical composition for treating gallstones is reasonable in formula, has the functions of soothing the liver, benefiting the gallbladder and promoting qi circulation to relieve pain, and is good in gallstone elimination effect, fast in acting, short in treatment course, free of toxic or side effect, simple in preparation method and convenient to operate on treatment of hepatic calculus and gallstones.

Description

technical field [0001] The invention relates to the field of gallstone treatment, in particular to a gallstone pharmaceutical composition and a preparation method thereof. Background technique [0002] Cholelithiasis, also known as cholelithiasis, refers to a disease in which stones occur in the biliary system, including the gallbladder or bile duct; biliary tract infection is a common disease. Divided into cholecystitis and cholangitis according to the site of onset. After the stones form in the gallbladder, they can stimulate the gallbladder mucosa, which can not only cause chronic inflammation of the gallbladder, but also cause secondary infection when the stones are incarcerated in the neck of the gallbladder or the cystic duct, leading to acute inflammation of the gallbladder. Chronic stimulation of the gallbladder mucosa by stones may also lead to the occurrence of gallbladder cancer. It has been reported that the incidence of gallbladder cancer can reach 1% to 2%. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P1/16
CPCA61K36/9066A61K9/0095A61K36/185A61K36/233A61K36/282A61K36/285A61K36/46A61K36/48A61K36/484A61K36/515A61K36/53A61K36/539A61K36/65A61K36/704A61K36/71A61K36/752A61K2300/00
Inventor 粟春生
Owner 粟春生
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com